In COVID-19 clinical update #90, Dr. Griffin covers FDA expansion for booster doses, 3 more at home antigen tests approved by FDA, immune correlates analysis of mRNA-1273 vaccine, risk for stillbirth, PROVENT prophylaxis trial results, fluvoxamine recommendations, advice on molnupiravir, automated text messaging service for monitoring illness, and long COVID-19 after vaccination and infection.
Click arrow to play
Download TWiV 831 (25 MB .mp3, 41 min)
Subscribe (free): iTunes, Google Podcasts, RSS, email
Show notes at microbe.tv/twiv